ERBB2/HER2: from molecular to clinical oncology;Onkogen ERBB2/HER2: ot molekuliarnoi k klinicheskoi onkologii.

Voprosy Onkologii

Volumn 48, Issue 2, 2002, Pages 137-145

  Khanson, K P ^a   Imianitov, E N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE; TRASTUZUMAB;

ANIMAL; BREAST TUMOR; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PROGNOSIS; PROTO ONCOGENE; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; PROGNOSIS; PROTEIN-TYROSINE KINASES; RECEPTOR, ERBB-2;

EID: 0036049927     PISSN: 05073758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)